4th Quarter - Report — HUMANA, INC. for HUMANA INC (2018)

Firm

HUMANA, INC.

Client

HUMANA INC

Income

—

Expenses

$320,000

Expense method

A: Lobbying Disclosure Act definitions

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

H.R. 246, Jobs and Premium Protection Act S. 1859, Healthcare Tax Relief Act H.R. 5963, Health Insurance Premium Reduction Act S. 3063, Health Insurance Tax Relief Act of 2018 H.R. 6311, Increasing Access to Lower Premium Plans and Expanding Health Savings Accounts Act of 2018 Tax Reform Implementation (P.L. 115-97)

Lobbyist	Covered position, as disclosed
RACHEL MAGNUSON	—
DEBRA OBERMAN	—
DOUGLAS STOSS	—

Contacted: SENATE; Office of Management & Budget (OMB); Health & Human Services, Dept of (HHS); White House Office; HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Treasury, Dept of

Bills named: H.R. 6311 (115th), S. 1859 (115th), H.R. 246 (115th), S. 3063 (115th), H.R. 5963 (115th)

Health Issues HCR

Bipartisan Healthcare Stabilization Act (Alexander-Murray) Affordable Care Act Implementation H.R. 2026 Pharmaceutical Information Exchange Act H.R. 878, H.R. 2368, S. 204 Right-to-Try Legislation S. 2554, Patient Right to Know Drug Prices Act

Lobbyist	Covered position, as disclosed
RACHEL MAGNUSON	—
DEBRA OBERMAN	—
DOUGLAS STOSS	—

Contacted: Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; White House Office; Health & Human Services, Dept of (HHS); Office of Management & Budget (OMB); Treasury, Dept of; SENATE

Bills named: H.R. 2368 (115th), H.R. 2026 (115th), S. 204 (115th), S. 2554 (115th), H.R. 878 (115th)

Medicare/Medicaid MMM

Medicare Advantage Policy and Reimbursement Part D Policy and Reimbursement Medicaid and Dual Eligible Issues Pharmacy Reimbursement Issues Medicare Access and CHIP Reauthorization Act Implementation HHS Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs Opioid Issues H.R. 6, Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act S. 3120, HEAL Act of 2018 S. 637, Creating Transparency to Have Drug Rebates Unlocked Act H.R. 3528, Every Prescription Conveyed Securely Act H.R. 6733, Know the Cost Act of 2018 S. 2553, Know the Lowest Price Act of 2018

Lobbyist	Covered position, as disclosed
RACHEL MAGNUSON	—
DEBRA OBERMAN	—
DOUGLAS STOSS	—

Contacted: White House Office; HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); SENATE; Office of Management & Budget (OMB); Treasury, Dept of

Bills named: H.R. 6733 (115th), S. 2553 (115th), S. 3120 (115th), S. 637 (115th), H.R. 6 (115th), H.R. 3528 (115th)

Defense DEF

Tricare Issues S. 2943, FY 2017 National Defense Authorization Act Implementation H.R. 2810/S. 1519, FY 2018 National Defense Authorization Act Implementation H.R. 5515 and S. 2987, FY 2019 National Defense Authorization Act

Lobbyist	Covered position, as disclosed
RACHEL MAGNUSON	—
DOUGLAS STOSS	—

Contacted: White House Office; Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Treasury, Dept of; Office of Management & Budget (OMB); SENATE; Centers For Medicare and Medicaid Services (CMS)

Bills named: S. 1519 (115th), H.R. 5515 (115th), S. 2987 (115th), S. 2943 (115th), H.R. 2810 (115th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.